Svoboda, et al., conducted a pilot study using a nonviral messenger RNA-vector transduced CD19-CAR T in patients with R/R cHL (NCT02277522 and NCT02624258) (163). This evidence concerns the gene CD19 and classic Hodgkin lymphoma.